Bulk Drugs & API Manufacturing

Gujarat Themis Biosyn reported audited FY26 results with net profit of ₹466.8 crore on revenue of ₹1,658.2 crore, approved by board on May 25, 2026. Company significantly expanded operations with ₹4,5